Lexaria Bioscience Corp. - COM NEW (LEXX)

CUSIP: 52886N406

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM NEW
Total 13F shares
456,920
Share change
+5,053
Total reported value
$1,849,000
Price per share
$4.04
Number of holders
10
Value change
-$8,044
Number of buys
6
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 52886N406?
CUSIP 52886N406 identifies LEXX - Lexaria Bioscience Corp. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q4 2021

As of 31 Dec 2021, Lexaria Bioscience Corp. - COM NEW (LEXX) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 456,920 shares. The largest 10 holders included Invenomic Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, UBS Group AG, Edge Wealth Management LLC, MD Financial Management Inc., ADVISOR GROUP HOLDINGS, INC., Tower Research Capital LLC (TRC), WELLS FARGO & COMPANY/MN, and ROYAL BANK OF CANADA. This page lists 10 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.